Your browser doesn't support javascript.
loading
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China.
Shenyu, Wang; Xiaoqian, Duan; Bo, Chen; Xuan, Deng; Zeng, Wang; Hangjie, Zhang; Qianhui, Zheng; Zhenzhen, Liang; Chuanfu, Yan; Juan, Yang; Gang, Zeng; Huakun, Lv.
Afiliación
  • Shenyu W; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, Zhejiang Province, China. Electronic address: sywang@cdc.zj.cn.
  • Xiaoqian D; Sinovac Biotech CO., Ltd., Beijing 100085, China. Electronic address: duanxiaoqian@sinovac.com.
  • Bo C; Kaihua County Center for Disease Control and Prevention, Quzhou 324300, Zhejiang Province, China. Electronic address: 362085291@qq.com.
  • Xuan D; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, Zhejiang Province, China. Electronic address: xdeng@cdc.zj.cn.
  • Zeng W; Sinovac Biotech CO., Ltd., Beijing 100085, China. Electronic address: wangzeng@sinovac.com.
  • Hangjie Z; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, Zhejiang Province, China. Electronic address: hjzhang@cdc.zj.cn.
  • Qianhui Z; Kaihua County Center for Disease Control and Prevention, Quzhou 324300, Zhejiang Province, China. Electronic address: zzliang@cdc.zj.cn.
  • Zhenzhen L; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, Zhejiang Province, China. Electronic address: zzliang@cdc.zj.cn.
  • Chuanfu Y; Kaihua County Center for Disease Control and Prevention, Quzhou 324300, Zhejiang Province, China.
  • Juan Y; School of Public Health, Xiamen University, Xiamen 361102, Fujian Province, China.
  • Gang Z; Sinovac Biotech CO., Ltd., Beijing 100085, China. Electronic address: zengg@sinovac.com.
  • Huakun L; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, Zhejiang Province, China. Electronic address: hklv@cdc.zj.cn.
Vaccine ; 40(36): 5356-5365, 2022 08 26.
Article en En | MEDLINE | ID: mdl-35933275
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacunas de Productos Inactivados / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacunas de Productos Inactivados / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos